Want to refine your search results? Try our advanced search.
Search results 6701 - 6710 of 43414 for WA 0812 2782 5310 Perusahaan Kontraktor Interior Set Kamar Ukiran Terpercaya Gondang Sragen.
Search results 6701 - 6710 of 43414 for WA 0812 2782 5310 Perusahaan Kontraktor Interior Set Kamar Ukiran Terpercaya Gondang Sragen.
CA Blank Order
setting. A worker in the community options program had attempted to find placement for Sandra
/ca/smd/DisplayDocument.html?content=html&seqNo=138094 - 2015-03-23
setting. A worker in the community options program had attempted to find placement for Sandra
/ca/smd/DisplayDocument.html?content=html&seqNo=138094 - 2015-03-23
2007 WI 6
to the facts and misconduct alleged by the OLR as set forth in the parties' stipulation. The misconduct giving
/sc/opinion/DisplayDocument.html?content=html&seqNo=27842 - 2007-01-18
to the facts and misconduct alleged by the OLR as set forth in the parties' stipulation. The misconduct giving
/sc/opinion/DisplayDocument.html?content=html&seqNo=27842 - 2007-01-18
State v. Randy J. Krueger
of statutory interpretation. The construction and application of a statute to a set of facts presents
/ca/opinion/DisplayDocument.html?content=html&seqNo=11489 - 2005-03-31
of statutory interpretation. The construction and application of a statute to a set of facts presents
/ca/opinion/DisplayDocument.html?content=html&seqNo=11489 - 2005-03-31
State v. Michael S. Alberts, Jr.
, was within the parameters of Jensen. Wisconsin's expert testimony law is set forth in Wis. Stat. § 907.02
/ca/opinion/DisplayDocument.html?content=html&seqNo=3722 - 2005-03-31
, was within the parameters of Jensen. Wisconsin's expert testimony law is set forth in Wis. Stat. § 907.02
/ca/opinion/DisplayDocument.html?content=html&seqNo=3722 - 2005-03-31
[PDF]
WI 100
a letter setting forth its concerns. The petitioner formally requested and received an extension
/sc/scord/DisplayDocument.pdf?content=pdf&seqNo=52680 - 2014-09-15
a letter setting forth its concerns. The petitioner formally requested and received an extension
/sc/scord/DisplayDocument.pdf?content=pdf&seqNo=52680 - 2014-09-15
Rule Order
, the WHLA filed a letter setting forth its concerns. The petitioner formally requested and received
/sc/scord/DisplayDocument.html?content=html&seqNo=52680 - 2010-07-26
, the WHLA filed a letter setting forth its concerns. The petitioner formally requested and received
/sc/scord/DisplayDocument.html?content=html&seqNo=52680 - 2010-07-26
[PDF]
CA Blank Order
for that of the agency or set aside its factual findings if they are supported by any reasonable view of the evidence
/ca/smd/DisplayDocument.pdf?content=pdf&seqNo=170190 - 2017-09-21
for that of the agency or set aside its factual findings if they are supported by any reasonable view of the evidence
/ca/smd/DisplayDocument.pdf?content=pdf&seqNo=170190 - 2017-09-21
[PDF]
May a judge testify at a Canadian administrative tribunal hearing on behalf of an interest group which seeks a binding administrative rule declaring that the Canadian Human Rights Act applies to the Canadian judiciary?
the judge's proposed testimony as barred by the considerations set out in SCR 60.05(1) which state
/sc/judcond/DisplayDocument.pdf?content=pdf&seqNo=876 - 2017-09-20
the judge's proposed testimony as barred by the considerations set out in SCR 60.05(1) which state
/sc/judcond/DisplayDocument.pdf?content=pdf&seqNo=876 - 2017-09-20
[PDF]
State v. Carl J. Knapp
. Knapp argues that the trial court erred by setting restitution at $2,000. The record shows the court
/ca/opinion/DisplayDocument.pdf?content=pdf&seqNo=9262 - 2017-09-19
. Knapp argues that the trial court erred by setting restitution at $2,000. The record shows the court
/ca/opinion/DisplayDocument.pdf?content=pdf&seqNo=9262 - 2017-09-19
COURT OF APPEALS
by the federal “reliability standard” for expert testimony set forth in Daubert v. Merrell Dow Pharmaceuticals
/ca/opinion/DisplayDocument.html?content=html&seqNo=118300 - 2014-07-28
by the federal “reliability standard” for expert testimony set forth in Daubert v. Merrell Dow Pharmaceuticals
/ca/opinion/DisplayDocument.html?content=html&seqNo=118300 - 2014-07-28